Document mpQqaGoe9xYNazGNmBVpJ5m9B

5U.-.I if DU PONT CENTRAL RESEARCH AND DEVELOPMENT HASKELL LABORATORY FOR TOXICOLOGY AND INDUSTRIAL MEDICINE TO: C. F. REINHARDT CR&D HASKELL LABORATORY DATE: SEPTEMBER 27, 1993 PROJECT HR 5754 PART I TITLE: In Vitro Method to Simulate Gastric Bioavailability of Lead Contaminated Soi1 Authority is requested to cover expenses ($7,000) associated with the study described above that were not covered by the original project (MR 9682). This covers methods development for the project. This amount will be billed in one installment in October, 1993. Amount requested $ 7,000 Previously authorized $ 1,025 Expended through / / $ General Ledger & Subaccount to be Charged ____ ____________ . ______ Forecast month and year Experiment to start: July, 1993 Experiment to end: September, 1993 Final report to issue: October, 1993 Request for study made by: H, Ghantous TESTING _X_ RESEARCH ___ CONSULTING (Check appropriate classification) If this request meets with your approval, please enter the GENERAL LEDGER AND SUBACCOUNT TO BE CHARGED, the CLASSIFICATION, and have it PROPERLY AUTHORIZED, ----------------------- Proposed by: Cost Code 19 22 24 25 30 31 32 Total {%) 100 Approved by: Authorized: PLEASE RETURN AUTHORIZED COPY DIRECTLY TO: LAURA WALLS, FINANCIAL SERVICES, HASKEL LABORATORY 11,4-If------Hanan Ghantous Vi 43 (date) This is a TSCA 8(d) chemical, (check if appropriate) hng/amb DUP040005001